Metastasizing mammary carcinomas in H19 enhancers-Igf2 transgenic mice

Journal of Experimental Zoology

Volumn 281, Issue 1, 1998, Pages 43-57

  Pravtcheva, Dimitrina D ^a,b   Wise, Thomas L ^a  

^a Pediatric Research Institute   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS; GROWTH FACTOR; METASTASIS; SOMATOMEDIN B; TUMOR CELL;

ANIMALIA; MUS MUSCULUS;

EID: 0032079677     PISSN: 0022104X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-010X(19980501)281:1<43::AID-JEZ7>3.0.CO;2-C     Document Type: Article

References (99)

1. Amundadottir, L.F., G. Merlino, and R.B. Dickson (1996) Transgenic mouse models of breast cancer. Breast Cancer Res. Treat., 39:119-135.
2. Arteaga, C.L., and C.K. Osborne (1989) Growth inhibition of human breast cancer cells in vitro with an antibody against the type I somatomedin receptor. Cancer Res., 49:6237-6241.
3. Baker, J., J.-P. Liu, E.J. Robertson, and A. Efstratiadis (1993) Role of insulin-like growth factors in embryonic and postnatal growth. Cell, 75:73-82.
4. Bartolomei, M.S., and S.M. Tilghman (1992) Parental imprinting of mouse chromosome 7. Sem. Dev. Biol., 3:107-118.
5. Bartolomei, M.S., S. Zemel, and S.M. Tilghman (1991) Parental imprinting of the mouse H19 gene. Nature, 351:153-155.
6. Bates, P., R. Fisher, A. Ward, L. Richardson, D.J. Hill, and C.F. Graham (1995) Mammary cancer in transgenic mice expressing insulin-like growth factor II (IGF-II). Br. J. Cancer, 72:1189-1193.
7. Beckwith, J.B. (1969) Macroglossia, omphalocele, adrenal cytomegaly, gigantism and hyperplastic visceromegaly. Birth Defects, 5:183-196.
8. Cariani, E., C. Lasserre, D. Seurin, B. Hamelin, F. Kemeny, D. Franco, M.P. Czech, A. Ullrich, and C. Brechst (1988) Differential expression of insulin-like growth factor II mRNA in human primary liver cancers, benign liver tumors, and liver cirrhosis. Cancer Res., 48:6844-6849.
9. Cariani, E., N. Dubois, C. Lasserre, P. Briand, and C. Brechst (1991) Insulin-like growth factor II (IGF-II) mRNA expression during hepatocarcinogenesis in transgenic mice. J. Hepatol., 13:220-226.
10. Chomczynski, P., and N. Sacchi (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162:156-159.
11. Cullen, K.J., H.S. Smith, S. Hill, N. Rosen, and M.E. Lippman (1991) Growth factor mRNA expression by human breast fibroblasts from benign and malignant tissues. Cancer Res., 57:4978-4985.
12. Cullen, K.J., A. Allison, I. Martire, M. Ellis, and C. Singer (1992) Insulin-like growth factor expression in breast cancer epithelium and stroma. Breast Cancer Res. Treat., 22:21-29.
13. Daughaday, W.H., and P. Rotwein (1989) Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum and tissue concentrations. Endocrin. Rev., 10:68-91.
14. DeChiara, T.M., A. Efstratiadis, and E.J. Robertson (1990) A growth deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature, 345:78-80.
15. DeChiara, T.M., E.J. Robertson, and A. Efstratiadis (1991) Parental imprinting of the mouse insulin-like growth factor II gene. Cell, 64:849-859.
16. De Leon, D.D., C. Terry, Y. Asmerom, and P. Nissley (1995) Insulin-like growth factor II modulates the routing of cathepsin D in MCF-7 breast cancer cells. Endocrinology, 137;1851-1859.
17. De Souza, A.T., G.R. Hankins, M.K. Washington, T.C. Orton, and R.L. Jirtle (1995) M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity. Nature Genet., 11:447-449.
18. Dennis, P.A., and D.B. Rifkin (1991) Cellular activation of latent transforming growth factor β requires binding to the cation-independent mannose-6-phosphate/insulin-like growth factor II receptor. Proc. Natl. Acad. Sci. USA, 88:580-584.
19. Ellis, M.J.C., B.A. Leav, Z. Yang, A. Rasmussen, A. Pearce, J.A. Zweibel, M.E. Lippman, and K.J. Cullen (1996) Affinity for the insulin-like growth factor-II (IGF-II) receptor inhibits autocrine IGF-II activity in MCF-7 breast cancer cells. Mol. Endocrinol., 10:286-297.
20. Filson, A.J., A. Louvi, A. Efstratiadis, and E.J. Robertson (1993) Rescue of the T-associated maternal effect in mice carrying null mutations in Igf-2 and Igf2r, two reciprocally imprinted genes. Development, 118:731-736.
21. Giani, C., K.J. Cullen, D. Campani, and A. Rasmussen (1996) IGF-II mRNA and protein are expressed in the stroma of invasive breast cancers: An in situ hybridization and immunohistochemistry study. Breast Cancer Res. Treat., 41:43-50.
22. Giannoukakis, N., C. Deal, J. Paquette, C.G. Goodyer, and C. Polychronakos (1993) Parental genomic imprinting of the human IGF2 gene. Nature Genet., 4:98-101.
23. Gucev, Z.S., Y. Oh, K.M. Kelley, and R.G. Rosenfeld (1996) Insulin-like growth factor binding protein 3 mediates retinoic acid-and transforming growth factor β2-induced growth inhibition in human breast cancer cells. Cancer Res., 56:1545-1550.
24. Guerra, F.K., A.M. Eijan, L. Puricelli, D.F. Alonso, E.B. de K. Joffe, A.B. Kornblihtt, E.H. Charreau, and P.V. Elizalde (1996) Varying patterns of expression of insulin-like growth factors I and II and their receptors in murine mammary adenocarcinomas of different metastasizing ability. Int. J. Cancer, 65:812-820.
25. Hadsell, D.L., N.M. Greenberg, J.M. Fligger, C.R. Baumrucker, and J.M. Rosen (1996) Targeted expression of des(1-3) Human insulin-like growth factor I in transgenic mice influences mammary gland development and IGF-binding protein expression. Endocrinol., 137:321-330.
26. Hankins, G.R., A.T. De Souza, R.C. Bentley, M.R. Patel, J.R. Marks, J.D. Iglehart, and R.L. Jirtle (1996) M6P/IGF2 receptor: a candidate breast tumor suppressor gene. Oncogene, 12:2003-2009.
27. Harrington, E.A., M.R. Bennett, A. Fanidi, and G.I. Evan (1994a) c-Myc-induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J., 13:3286-3295.
28. Harrington, E.A., A. Fanidi, and G.I. Evan (1994b) Oncogenes and cell death. Curr. Opin. Genet. Dev., 4:120-129.
29. Haselbacher, G.K., J.-C. Irminger, J. Zapf, W.H. Ziegler, and R.E. Humbel (1987) Insulin-like growth factor II in human adrenal pheochromocytomas and Wilms' tumors. Expression at the mRNA and protein levels. Proc. Natl. Acad. Sci. USA, 84:1104-1106.
30. Hatada, I., J. Inozawa, T. Abe, M. Nakayama, Y. Kaneko, Y. Jinno, N. Niikawa, H. Ohashi, Y. Fukushima, K. Iida, C. Yutani, S.-I. Takahashi, Y. Chiba, S. Ohishi, and T. Mukai (1996) Genomic imprinting of human p57kip2 and its reduced expression in Wilms tumors. Human Mol. Genet., 5:783-788.
31. Hedborg, F., L. Holmgren, B. Sandstedt, and R. Ohlsson (1994) The cell type-specific IGF2 expression during early human development correlates to the pattern of overgrowth and neoplasia in the Beckwith-Wiedemann syndrome. Am. J. Pathol., 145:802-817.
32. Hogan, B., R. Beddington, F. Costantini, and E. Lacy (1994) Manipulating the Mouse Embryo. A Laboratory Manual. 2nd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
33. Johnson, D.R. (1974) Hairpin-Tail: a case of post-reductional gene action in the mouse egg? Genetics, 76:795-805.
34. Junien, C. (1992) Beckwith-Wiedemann syndrome, tumorigenesis and imprinting. Curr. Opin. Genet. Dev., 2:431-438.
35. Karey, K.P., and D.A. Sirbasku (1988) Differential responsiveness of human breast cancer cell lines MCF-7 and T47D to growth factors and 17-β-estradiol. Cancer Res., 48:4083-4092.
36. Kiess, W., C.L. Thomas, L.A. Greenstein, L. Lee, M.M. Sklar, M.M. Rechler, G.G. Sahagian, and S.P. Nissley (1989) Insulin-like growth factor II (IGF-II) inhibits both the cellular uptake of β-galactosidase and the binding of β-galactosidase to purified IGF-II//mannose 6-phosphate receptor. J. Biol. Chem., 264:4710-4714.
37. Kornfeld, S. (1992) Structure and function of the mannose 6-phosphate/insulin-like growth factor II receptors. Annu. Rev. Biochem., 61:307-330.
38. Lau, M.M.H., C.E.H. Stewart, Z. Liu, H. Bhatt, P. Rotwein, and C.L. Stewart (1994) Loss of the imprinted IGF2/cation-independent mannose 6-phosphate receptor results in fetal overgrowth and perinatal lethality. Genes Dev., 8:2953-2963.
39. Leder, A., P.K. Pattengale, A. Kuo, T.A. Stewart, and P. Leder (1986) Consequences of widespread deregulation of the c-myc gene in transgenic mice: Multiple neoplasms and normal development. Cell, 45;485-495.
40. Lee, J.E., J. Pintar, and A. Efstratiadis (1990) Pattern of the insulin-like growth factor II gene expression during early mouse embryogenesis. Development, 110:151-159.
41. Leighton, P.A., R.S. Ingram, J. Eggenschwiler, A. Efstratiadis, and S.M. Tilghman (1995a) Disruption of imprinting caused by deletion of the H19 gene region in mice. Nature, 375:34-39.
42. Leighton, P.A., J.R. Saam, R.S. Ingram, C.L. Stewart, and S.M. Tilghman (1995b) An enhancer deletion affects both H19 and Igf2 expression. Genes Dev., 9:2079-2089.
43. Liu, J.-P., J. Baker, A.S. Perkins, E.J. Robertson, and A. Efstratiadis (1993) Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 Igf receptor (Igf1r). Cell, 75:59-72.
44. Louvi, A., D. Accili, and A. Efstratiadis (1997) Growth-promoting interaction of IGFII with the insulin receptor during mouse embryonic development. Dev. Biol., 189:33-48.
45. Ludwig, T., J. Eggenschwiler, P. Fisher, A.J. D'Ercole, M.L. Davenport, and A. Efstratiadis (1996) Mouse mutants lacking the type 2 IGF receptor (IGF2R) are rescued from perinatal lethality in Igf2 and Igf1r null backgrounds. Dev. Biol., 177:517-535.
46. Mahler, J.F., W. Stokes, P.C. Mann, M. Takaoka, and R.R. Maronpot (1996) Spontaneous lesions in aging FVB/N mice. Toxicol. Pathol., 24:710-716.
47. Manni, A., B. Badger, L. Wei, A. Zasenglein, R. Grove, S. Khin, D. Heitjan, S. Shimasaki, and N. Ling (1994) Hormonal regulation of insulin-like growth factor II and insulin-like growth factor binding protein expression by breast cancer cells in vivo: Evidence for stromal epithelial interactions. Cancer Res., 54:2934-2942.
48. Mathews, L.S., R.E. Hammer, R.R. Behringer, A.J. D'Ercole, G.I. Bell, R.L. Brinster, and R.D. Palmiter (1988) Growth enhancement in transgenic mice expressing human insulin-like growth factor I. Endocrinology, 123:2827-2833.
49. Mathieu, M., H. Rochefort, B. Barenton, C. Prebois, and F. Vignon (1990) Interactions of cathepsin-D and IGF-II on the IGF-II/M6P receptor in human breast cancer cells and possible consequences on mitogenic activity of IGF-II. Mol. Endocrinol., 4:1327-1335.
50. McCann, A.H., N. Miller, A. O'Meara, I. Pedersen, K. Keogh, T. Gorey, and P.A. Dervan (1996) Biallelic expression of the IGF2 gene in human breast disease. Hum. Mol. Genet., 5:1123-1127.
51. McCusker, R.H., and D.R. Clemmons (1992) The insulin-like growth factor binding proteins: structure and biological functions. In: The Insulin-Like Growth Factors. P.N. Schofield, ed. Oxford University Press, New York, pp. 110-150.
52. Medina, D. (1973) Preneoplastic lesions in mouse mammary tumorigenesis. Cancer Res., 7:3-53.
53. Morrione, A., B. Valentinis, S.-Q. Xu, G. Yumet, A. Louvi, A. Efstratiadis, and R. Baserga (1997) Insulin-like growth factor II stimulates cell proliferation through the insulin receptor. Proc. Natl. Acad. Sci. USA, 94:3777-3782.
54. Moxham, C., and S. Jacobs (1992) Insulin-like growth factor receptors. In: The Insulin-Like Growth Factors. P.N. Schofield, ed. Oxford University Press, New York, pp. 80-109.
55. Naik, P., J. Karrim, and D. Hanahan (1996) The rise and fall of apoptosis during multistage tumorigenesis: down-modulation contributes to tumor progression from angiogenic progenitors. Genes Dev., 10:2105-2116.
56. Neuenschwander, S., A. Schwartz, T.L. Wood, C.T. Roberts, Jr., L. Henninghausen, and D. LeRoith (1996) Involution of the lactating mammary glands is inhibited by the IGF system in a transgenic mouse model. J. Clin. Invest., 97:2225-2232.
57. Oh, Y., H.L. Müller, D.-Y. Lee, P.J. Fielder, and R.G. Rosenfeld (1993a) Characterization of the affinities of insulin-like growth factor (IGF)-binding proteins 1-4 for IGF-I, IGF-II, IGF-I/Insulin hybrid, and IGF-I analogs. Endocrinology, 132:1337-1344.
58. Oh, Y., H.L. Müller, G. Lamson, and R.G. Rosenfeld (1993b) Insulin-like growth factor (IGF)-independent action of IGF binding protein-3 in Hs578T human breast cancer cells. J. Biol. Chem., 268:14964-14971.
59. Oh, Y., H.L. Müller, L. Ng, and R.G. Rosenfeld (1995) Transforming growth factor β-induced cell growth inhibition in human breast cancer cells is mediated through insulin-like growth factor-binding protein-3 action. J. Biol. Chem., 270:13589-13592.
60. Ohlsson, R., A. Nyström, S. Pfeifer-Ohlsson, V. Töhönen, F. Hedborg, P. Schofield, F. Flam, and T.J. Ekström (1993) Igf2 is parentally imprinted during human embryogenesis and in Beckwith-Wiedemann syndrome. Nature Genet., 4:94-97.
61. Pekonen, F., S. Partanen, T. Makinen, and E.M. Rutanen (1988) Receptors for epidermal growth factor and insulin-like growth factor I and their relation to steroid receptors in human breast cancer. Cancer Res., 48:1343-1347.
62. Peyrat, J.P., and J. Bonneterre (1992) Type I IGF receptor in human breast diseases. Breast Cancer Res. Treat., 22:59-67.
63. Pierce, D.F., A.E. Gorska, A. Chytil, K.S. Meise, D.L. Page, R.J. Coffey, and H.L. Moses (1995) Mammary tumor suppression by transforming growth factor β1 transgene expression. Proc. Natl. Acad. Sci. USA, 92:4254-4258.
64. Pravtcheva, D.D., C.N. Adra, and F.H. Ruddle (1991) Timing of paternal PGK-1 expression in embryos of transgenic mice. Development, 111:1109-1120.
65. Quinn, K.A., A.M. Treston, E.J. Unsworth, M.-J. Miller, M. Vos, C. Grimley, J. Battey, J.L. Mulshine, and F. Cuttitta (1996) Insulin-like growth factor expression in human cancer cell lines. J. Biol. Chem., 271:11477-11483.
66. Raff, M.C., B.A. Barres, J.F. Burne, H.S. Coles, Y. Ishizaki, and M.D. Jacobson (1993) Programmed cell death and the control of cell survival: Lessons from the nervous system. Science, 262:695-700.
67. Reeve, A.E., M.R. Ecoles, R.J. Wilkins, G.I. Bell, and L.J. Millow (1985) Expression of insulin-like growth factor II transcripts in Wilms' tumor. Nature, 317:258-260.
68. Resnicoff, M., D. Abraham, W. Yutanawiboonchai, H.L. Rotman, J. Kajstura, R. Rubin, P. Zoltick, and R. Baserga (1995) The insulin-like growth factor I receptor protects tumor cells from apoptosis in vivo. Cancer Res., 55:2463-2469.
69. Ripoche, M.A., C. Kress, F. Pirier, and L. Dandolo (1997) Deletion of the H19 transcription unit reveals the existence of a putative imprinting control element. Genes Dev., 11:1596-1604.
70. Robinson, S.D., G.B. Silberstein, A.B. Roberts, K.C. Flanders, and C.W. Daniel (1991) Regulated expression and growth inhibitory effect of transforming growth factor β isoforms in mouse mammary gland development. Development, 113:867-878.
71. Rogler, C.E., D. Yang, L. Rossetti, J. Donohoe, E. Alt, C.J. Chang, R. Rosenfeld, K. Neely, and R. Hintz (1994) Altered body composition and increased frequency of diverse malignancies in insulin-like growth factor transgenic mice. J. Biol. Chem., 269:13779-13784.
72. Rohlik, Q.T., D. Adams, F.C. Kull, Jr., and S. Jacobs (1987) An antibody to the receptor for insulin-like growth factor I inhibits the growth of MCF-7 cells in tissue culture. Biochem. Biophys. Res. Commun., 149;276-281.
73. Rotwein, P., and L.J. Hall (1990) Evolution of insulin-like growth factor II: Characterization of the mouse IGF-II gene and identification of two pseudoexons. DNA Cell Biol., 9:725-735.
74. Sambrook, J., E.F. Fritsch, and T. Maniatis (1989) Molecular Cloning. A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
75. Sandgren, E.P., J.A. Schroeder, T.H. Qui, R.D. Palmiter, R.L. Brinster, and D.C. Lee (1995) Inhibition of mammary gland involution is associated with transforming growth factor α, but not c-myc-induced tumorigenesis in transgenic mice. Cancer Res., 55:3915-3927.
76. Sara, V.R., and K. Hall (1990) Insulin-like growth factors and their binding proteins. Physiol. Rev., 70:591-614.
77. Schirmacher, P., W.A. Held, D. Yang, F.V. Chisari, Y. Rusbum, and C.E. Rogler (1992) Reactivation of insulin-like growth factor II during hepatocarcinogenesis in transgenic mice suggests a role in malignant growth. Cancer Res., 52:2549-2556.
78. Scott, J., J. Cowell, M.E. Robertson, L.M. Priestley, R. Wadey, B. Hopkins, J. Pritchard, G.I. Bell, L.B. Rall, C.F. Graham, and T.J. Knott (1985) Insulin-like growth factor II gene expression in Wilms' tumour and embryonic tissues. Nature, 317:260-262.
79. Singer, C., A. Rasmussen, H.S. Smith, M.E. Lippman, H.T. Lynch, and K.J. Cullen (1995) Malignant breast epithelium selects for insulin-like growth factor II expression in breast stroma: evidence for paracrine function. Cancer Res., 55:2448-2454.
80. Sinn, E., W. Muller, P. Pattengale, I. Tepler, R. Wallace, and P. Leder (1987) Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: Synergistic action of oncogenes in vivo. Cell, 49:465-475.
81. Squartini, F., and R. Pingitore (1994) Tumors of the mammary gland. In: Pathology of tumors in laboratory animals, Vol. 2 - Tumors of the mouse. IARC Scientific Publications #111. V.S. Turusov and U. Mohr, eds. Lyon, France, pp. 47-100.
82. Stewart, T.A., P.K. Pattengale, and P. Leder (1984) Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes. Cell, 38:627-637.
83. Stewart, A.J., M.D. Johnson, F.E.B. May, and B.R. Westley (1990) Role of insulin-like growth factors and the type I insulin-like growth factor receptor in the estrogen-stimulated proliferation of human breast cancer cells. J. Biol. Chem., 265:21172-21178.
84. Stylianopoulou, F., A. Efstratiadis, J. Herbert, and J. Pintar (1988a) Pattern of insulin-like growth factor II gene expression during rat embryogenesis. Development, 103:497-506.
85. Stylianopoulou, F., J. Herbert, M.B. Soares, and A. Efstratiadis (1988b) Expression of the insulin-like growth factor II gene in the choroid plexus and the leptomeninges of the adult rat central nervous system. Proc. Natl. Acad. Sci. USA, 85:141-145.
86. Sympson, C.J., R.S. Talhouk, C.M. Alexander, J.R. Chin, S.M. Clift, M.J. Bissel, and Z. Werb (1994) Targeted expression of stromelysin-1 in mammary gland provides evidence for a role of proteinases in branching morphogenesis and the requirement for an intact basement membrane in tissue specific gene expression. J. Cell Biol., 125:681-693.
87. Thompson, J.S., K.J. Reese, M.R. DeBaun, E.J. Perlman, and A. Feinberg (1996) Reduced expression of the cyclin-dependent kinase inhibitor gene p57KIP2 in Wilm's tumor. Cancer Res., 56:5723-5727.
88. van Buul-Offers, S.C., K. de Haan, M.G. Reijnen-Gresnigt, D. Meinsma, M. Jansen, S.L. Oei, E.J. Bonte, J.S. Sussenbach, and J.L. Van den Brande (1995) Overexpression of human insulin-like growth factor-II in transgenic mice causes increased growth of the thymus. J. Endocrinol., 144:491-502.
89. Wang, T.C., R. Cardiff, L. Zukerberg, E. Lees, A. Arnord, and E.V. Schmidt (1994a) Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature, 369:669-671.
90. Wang, Z.-Q., M.R. Fung, D.P. Barlow, and E.F. Wagner (1994b) Regulation of embryonic growth and lysosomal targeting by the imprinted Igf2/Mpr gene. Nature, 372:464-467.
91. Ward, A., P. Bates, R. Fisher, L. Richardson, and C.F. Graham (1994) Disproportionate growth in mice with Igf2 transgenes. Proc. Natl. Acad. Sci. USA, 91:10365-10369.
92. Werner, H.M. and D. LeRoith (1996) The role of the insulin-like growth factor system in human cancer. Adv. Cancer Res., 68:183-223.
93. Wiedemann, H.R. (1983) Tumors and hemihypertrophy associated with Wiedemann-Beckwith syndrome. Eur. J. Pediat., 141:129.
94. Winking, H., and L.M. Silver (1984) Characterization of a recombinant mouse t haplotype that expresses a dominant lethal maternal effect. Genetics, 108:1013-1020.
95. Wise, T.L., and D.D. Pravtcheva (1997) Perinatal lethality in H19 enhancers-Igf2 transgenic mice. Mol. Reprod. Dev., 48:194-207.
96. Yballe, C.M., T.H. Vu, and A.R. Hoffman (1996) Imprinting and expression of insulin-like growth factor II and H19 in normal human breast tissue and breast tumor. J. Clin. Endocrinol. Metab., 81:1607-1612.
97. Yoo-Warren, H., V. Pachnis, R.S. Ingram, and S.M. Tilghman (1988) Two regulatory domains flank the mouse H19 gene. Mol. Cell. Biol., 8:4707-4715.
98. Zemel, S., M.S. Bartolomei, and S.M. Tilghman (1992) Physical linkage of two mammalian imprinted genes, H19 and insulin-like growth factor 2. Nature Genet, 2:61-64.
99. Zhang, Y., T. Shields, T. Crenshaw, Y. Hao, T. Moulton, and B. Tycko (1993) Imprinting of human H19: Allele-specific CpG methylation, loss of the active allele in Wilms' tumor, and potential for somatic allele switching. Am. J. Hum. Genet., 53:113-124.